Vaxcyte EVP, Chief Scientific Officer and COO Jim Wassil disposes of common shares worth $493,376.94
Reuters2026/09/09 21:47- Vaxcyte EVP, Chief Scientific Officer, COO Jim Wassil cut his stake to 145,435 shares through sales, tax-related share surrender.
- Sold 2,715 common shares on Sept. 4 and Sept. 9 at weighted-average prices of USD 61.16 and USD 59.52.
- Surrendered 5,459 shares on Sept. 8 at USD 60.36 to cover tax withholding tied to RSU vesting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
JPMorgan resumes coverage of Lithium Americas (LAC.US) and upgrades to "Overweight", target price of $6.
Lithium Americas (LAC.US) shares rose 6% on Wednesday after JPMorgan resumed coverage and raised its rating to "Overweight" with a target price of $6.

Charlie Hospital Semarang says no material information behind share-price volatility
Venteny Fortuna International files corrected annual public expose materials
Abu Dhabi Mubadala Strategic Investment in Luckin Coffee Explained: Transfer of Preferred Shares by New and Old Funds, Transaction Size Around 1 billion USD
The beneficial ownership of Dachen remains unchanged.